Cardiff Oncology, Inc. short interest in 2026
In 2026, Cardiff Oncology, Inc.'s disclosed short interest ran from 24.07% of shares outstanding on 15 Jan 2026 to 15.82% on 15 Sep 2026, a change of -8.25 percentage points. The year's high was 27.20% on 15 Apr 2026 and its low 15.02% on 31 Aug 2026, averaging 22.70% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.33 days on 31 Mar 2026. Full history: Cardiff Oncology, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 24.07% (15 Jan 2026)
- End of year
- 15.82% (15 Sep 2026)
- Change
- -8.25 pp
- High
- 27.20% (15 Apr 2026)
- Low
- 15.02% (31 Aug 2026)
- Average
- 22.70%
- Highest days to cover
- 32.33 (31 Mar 2026)
- SEC filings marked
- 5
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 24.07% | 17.48 | |
| 30 Jan 2026 | 25.52% | 6.35 | |
| 13 Feb 2026 | 26.69% | 21.31 | |
| 27 Feb 2026 | 26.25% | 23.46 | 10-K filed |
| 13 Mar 2026 | 25.86% | 27.04 | |
| 31 Mar 2026 | 26.60% | 32.33 | |
| 15 Apr 2026 | 27.20% | 22.21 | |
| 30 Apr 2026 | 26.87% | 29.02 | |
| 15 May 2026 | 26.35% | 26.88 | 10-Q filed, results (8-K) |
| 29 May 2026 | 26.52% | 12.28 | |
| 15 Jun 2026 | 23.62% | 7.96 | |
| 30 Jun 2026 | 18.74% | 7.76 | |
| 15 Jul 2026 | 17.68% | 6.16 | |
| 31 Jul 2026 | 17.84% | 9.26 | |
| 14 Aug 2026 | 15.29% | 15.27 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 15.02% | 18.16 | |
| 15 Sep 2026 | 15.82% | 12.06 |
See also: Cardiff Oncology, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.